论文部分内容阅读
研究目的主要是检验安度利可在精神分裂症维持治疗中的疗效。经过第一阶段6个月的HD治疗后,继以两年的维持治疗,其有效率为75~90%;BPRS-R、CGI-SI、SDSS总分,在整个维持治疗过程中均有显著性差异(F检验,P<0.01),维持治疗前后也有显著性差异(配对t检验,P<0.01)。结果表明,原来安度利可治疗有效的病例,再以安度利可治疗多数病人稳定;安度利可不仅能维持原先治疗的效果,而且还能使疗效进一步得到提高。另外,副反应相对少而轻,安全方便,注射给药还能解决精神病人治疗不合作的弊端。
The main purpose of this study was to examine the efficacy of Androlidine in the maintenance of schizophrenia. After the first phase of 6 months of HD treatment, followed by two years of maintenance therapy, the effective rate was 75 to 90%; BPRS-R, CGI-SI, SDSS total score throughout the maintenance treatment were significant Sex differences (F test, P <0.01), before and after maintenance therapy were also significantly different (paired t test, P <0.01). The results showed that the original Amway treatment of effective cases, followed by treatment with Amway most patients stable; Andulide can not only maintain the effect of the original treatment, but also to make the effect can be further improved. In addition, the side reactions are relatively small and light, safe and convenient, injecting medication can also solve the drawbacks of mental patients do not cooperate.